Terms: = Kidney tumors AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Treatment
137 results:
1. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract] [Full Text] [Related]
2. Paris polyphylla ethanol extract and polyphyllin I ameliorate adenomyosis by inhibiting epithelial-mesenchymal transition.
Shi YX; Xu L; Wang X; Zhang KK; Zhang CY; Liu HY; Ding PP; Shi W; Liu ZY
Phytomedicine; 2024 May; 127():155461. PubMed ID: 38452697
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Treg-related prognostic molecular subtypes and individualized characteristics in clear cell renal cell carcinoma through single-cell transcriptomes and bulk RNA sequencing.
Weng KQ; Liu JY; Li H; She LL; Qiu JL; Qi H; Qi HY; Li YS; Dai YB
Int Immunopharmacol; 2024 Mar; 130():111746. PubMed ID: 38442575
[TBL] [Abstract] [Full Text] [Related]
4. Deep learning algorithm (YOLOv7) for automated renal mass detection on contrast-enhanced MRI: a 2D and 2.5D evaluation of results.
Anari PY; Lay N; Zahergivar A; Firouzabadi FD; Chaurasia A; Golagha M; Singh S; Homayounieh F; Obiezu F; Harmon S; Turkbey E; Merino M; Jones EC; Ball MW; Linehan WM; Turkbey B; Malayeri AA
Abdom Radiol (NY); 2024 Apr; 49(4):1194-1201. PubMed ID: 38368481
[TBL] [Abstract] [Full Text] [Related]
5. Interaction between Wnt/β-catenin signaling pathway and emt pathway mediates the mechanism of sunitinib resistance in renal cell carcinoma.
Cai F; Li J; Zhang Y; Huang S; Liu W; Zhuo W; Qiu C
BMC Cancer; 2024 Feb; 24(1):175. PubMed ID: 38317072
[TBL] [Abstract] [Full Text] [Related]
6. The effect of Ganoderma lucidum polysaccharide extract on sensitizing prostate cancer cells to flutamide and docetaxel: an in vitro study.
Rahimnia R; Akbari MR; Yasseri AF; Taheri D; Mirzaei A; Ghajar HA; Farashah PD; Baghdadabad LZ; Aghamir SMK
Sci Rep; 2023 Nov; 13(1):18940. PubMed ID: 37919464
[TBL] [Abstract] [Full Text] [Related]
7. Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma.
Wang T; Zhou Y; Bao H; Liu B; Wang M; Wang L; Pan T
J Cell Mol Med; 2023 Dec; 27(23):3897-3910. PubMed ID: 37859585
[TBL] [Abstract] [Full Text] [Related]
8. [CT texture analysis for predicting pseudoprogression in metastatic clear cell renal cell carcinoma during PD-1 inhibitor therapy].
Zheng BJ; Xu WJ; Zhao LD; Xu CM; Li HL
Zhonghua Nei Ke Za Zhi; 2023 Sep; 62(9):1114-1120. PubMed ID: 37650185
[No Abstract] [Full Text] [Related]
9. PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation.
Rezaei S; Nikpanjeh N; Rezaee A; Gholami S; Hashemipour R; Biavarz N; Yousefi F; Tashakori A; Salmani F; Rajabi R; Khorrami R; Nabavi N; Ren J; Salimimoghadam S; Rashidi M; Zandieh MA; Hushmandi K; Wang Y
Eur J Pharmacol; 2023 Sep; 955():175909. PubMed ID: 37490949
[TBL] [Abstract] [Full Text] [Related]
10. Soluble dipeptidyl peptidase-4 induces epithelial-mesenchymal transition through tumor growth factor-β receptor.
Huang CW; Lee SY; Du CX; Ku HC
Pharmacol Rep; 2023 Aug; 75(4):1005-1016. PubMed ID: 37233949
[TBL] [Abstract] [Full Text] [Related]
11. ApoM suppresses kidney renal clear cell carcinoma growth and metastasis via the Hippo-YAP signaling pathway.
Xu T; Wei D; Yang Z; Xie S; Yan Z; Chen C; Hu W; Shi Z; Zhao Y; Cui M; Xu Z; Wang J
Arch Biochem Biophys; 2023 Jul; 743():109642. PubMed ID: 37211224
[TBL] [Abstract] [Full Text] [Related]
12. Regulating lactate-related immunometabolism and emt reversal for colorectal cancer liver metastases using shikonin targeted delivery.
Long L; Xiong W; Lin F; Hou J; Chen G; Peng T; He Y; Wang R; Xu Q; Huang Y
J Exp Clin Cancer Res; 2023 May; 42(1):117. PubMed ID: 37161591
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of complement C5a indicates poor survival and therapeutic response in metastatic renal cell carcinoma.
Yang C; Yang F; Chen X; Li Y; Hu X; Guo J; Yao J
Int J Biol Markers; 2023 Jun; 38(2):124-132. PubMed ID: 36883235
[TBL] [Abstract] [Full Text] [Related]
14. Phospholipase C delta 1 inhibits WNT/β-catenin and EGFR-FAK-ERK signaling and is disrupted by promoter CpG methylation in renal cell carcinoma.
Xie J; Zhou J; Xia J; Zeng Y; Huang G; Zeng W; Fan T; Li L; Zeng X; Tao Q
Clin Epigenetics; 2023 Feb; 15(1):30. PubMed ID: 36849889
[TBL] [Abstract] [Full Text] [Related]
15. Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer.
Huang Q; Liu M; Zhang D; Lin BB; Fu X; Zhang Z; Zhang B; Dong JT
BMC Med; 2023 Feb; 21(1):68. PubMed ID: 36810084
[TBL] [Abstract] [Full Text] [Related]
16. SF3B4 promotes Twist1 expression and clear cell renal cell carcinoma progression by facilitating the export of KLF 16 mRNA from the nucleus to the cytoplasm.
Yang Z; Wang YX; Wen JK; Gao HT; Han ZW; Qi JC; Gu JF; Zhao CM; Zhang H; Shi B; Wang DD; Wang XL; Qu CB
Cell Death Dis; 2023 Jan; 14(1):26. PubMed ID: 36639679
[TBL] [Abstract] [Full Text] [Related]
17. RBM4 inhibits the growth of clear cell renal cell carcinoma by enhancing the stability of p53 mRNA.
Jian W; Xue W; Wang T; Yu Y; Cai L; Meng Y; Xia Z; Zhang C
Mol Carcinog; 2023 Apr; 62(4):464-478. PubMed ID: 36585906
[TBL] [Abstract] [Full Text] [Related]
18. ENO2 affects the emt process of renal cell carcinoma and participates in the regulation of the immune microenvironment.
Chen WJ; Yang W; Gong M; He Y; Xu D; Chen JX; Chen WJ; Li WY; Wang YQ; Dong KQ; Song X; Pan XW; Cui XG
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562383
[TBL] [Abstract] [Full Text] [Related]
19. Extracellular Vesicles as Mediators of Nickel-Induced Cancer Progression.
Liu S; Ortiz A; Stavrou A; Talusan AR; Costa M
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555753
[TBL] [Abstract] [Full Text] [Related]
20. The effect of mesenchymal stem cells-derived exosomes on the prostate, bladder, and renal cancer cell lines.
Rezaeian A; Khatami F; Heidari Keshel S; Akbari MR; Mirzaei A; Gholami K; Mohammadi Farsani R; Aghamir SMK
Sci Rep; 2022 Dec; 12(1):20924. PubMed ID: 36463254
[TBL] [Abstract] [Full Text] [Related]
[Next]
